awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q42325009-25C56961-9B7C-4281-8A83-2F6B92B20E5A
Q42325009-25C56961-9B7C-4281-8A83-2F6B92B20E5A
BestRank
Statement
http://www.wikidata.org/entity/statement/Q42325009-25C56961-9B7C-4281-8A83-2F6B92B20E5A
Low-dose clofarabine in combination with a standard remission induction in patients aged 18-60 years with previously untreated intermediate and bad-risk acute myeloid leukemia or high-risk myelodysplastic syndrome: combined phase I/II results of the
P2860
Q42325009-25C56961-9B7C-4281-8A83-2F6B92B20E5A
BestRank
Statement
http://www.wikidata.org/entity/statement/Q42325009-25C56961-9B7C-4281-8A83-2F6B92B20E5A
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
d09fe4daa9caa0ab0db98f3061176b8180435642
P2860
Clofarabine in combination with a standard remission induction regimen (cytosine arabinoside and idarubicin) in patients with previously untreated intermediate and bad-risk acute myelogenous leukemia (AML) or high-risk myelodysplastic syndrome (HR-M